Why we invested in Ynsect
Today, Ynsect, the first bio-refinery of insects in the world, announced its $15.3m series B, bringing the company’s total funding to $37.7m. Future Positive Capital (my new investment firm) co-led the round, alongside Bpifrance Ecotechnologies, Quadia SA and the previous investors also chipped in, including Emertec, Demeter and New Protein Capital.
Sofia joined the board as Director. Since this is our first public investment and given the growing interest in the alternative protein space, I wanted to take a moment to share why we invested.Read More